However, because mice with CFTR mutations did not develop “spontaneous” chronic bacterial infection and/or inflammation in the lungs, CF mice are not a suitable animal model for testing gene therapies of CF lung disease (Wilke et al., 2011). This evidence concerns the gene CFTR and cystic fibrosis.